Emerald Advisers’s Imago BioSciences, Inc. Common stock IMGO Stock Holding History

Emerald Advisers’s Portfolio IMGO Stock Details IMGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-853,637	Closed	-$12.8M	–	266
2022 Q3	$12.8M	Buy	853,637 +30,575	+4%	+$496K	0.66%	72
2022 Q2	$11M	Buy	823,062 +206,694	+34%	+$3.28M	0.57%	77
2022 Q1	$11.9M	Buy	616,368 +40,209	+7%	+$834K	0.45%	86
2021 Q4	$13.7M	Buy	576,159 +4,130	+0.7%	+$95.7K	0.5%	78
2021 Q3	$11.5M	Buy	+572,029	New	+$12.3M	0.42%	92

Other funds holding IMGO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return

OFM

Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return

Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Versor Investments New York $40.8M AUM 93.59% 1-Year Est. Return

TAL

TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Emerald Advisers's IMGO Position: Q4 2022 in Review

Emerald Advisers sold out of Imago BioSciences, Inc. Common stock (IMGO) in Q4 2022, closing a stake of 853,637 shares — an estimated $12.8M sold.

Emerald Advisers first reported a position in IMGO in Q3 2021 and held it in 5 quarters. The position peaked at $13.7M in Q4 2021. 106 funds tracked by Wall St. Rank hold IMGO as of Q4 2022.

Emerald Advisers reported no remaining Imago BioSciences, Inc. Common stock position as of Q4 2022 after selling out during the quarter.
Emerald Advisers sold 853,637 Imago BioSciences, Inc. Common stock shares in Q4 2022, an estimated $12.8M.
Emerald Advisers first reported a position in Imago BioSciences, Inc. Common stock in Q3 2021 and held it in 5 quarters.
Emerald Advisers's Imago BioSciences, Inc. Common stock position peaked at $13.7M in Q4 2021.
106 funds tracked by Wall St. Rank held Imago BioSciences, Inc. Common stock as of Q4 2022.

Based on Emerald Advisers's 13F filing for Q4 2022, filed 3 Feb 2023.